Organigram Global (OGI) Restructuring Costs (2024 - 2026)
Organigram Global (OGI) reported Restructuring Costs of $3.2 million for Q1 2026, up 367.95% year-over-year from $678796.6 in Q1 2025, and up 175.82% quarter-over-quarter from $1.2 million in Q4 2025.
Organigram Global (OGI) Restructuring Costs (2024 - 2026) Analysis & Trends
Organigram Global (OGI) has 3 years of Restructuring Costs data on file, last reported at $3.2 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Organigram Global | 731.20 Mn | 673.26 Mn | 11.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.18 Mn |
| Dec 31, 2025 | 1.15 Mn |
| Mar 31, 2025 | 678,796.65 |
| Dec 31, 2024 | 3.22 Mn |